Objective: To develop an HPLC method for the determination of related substances and assay of levamisole hydrochloride tablets. Methods: The chromatographic separation of related substances was performed on a Thermo Hypsil C18 column(100 mm×4.6 mm, 3 μm). A gradient elution was applied with a mobile phase composed of 0.75% monobasic ammonium phosphate solution(adjusted at pH 6.5 with diiopropylamine) and acetonitrile. The assay analytical column was packed with IntertSustain C18 column(150 mm×4.6 mm, 5 μm). The mobile phase was 70 volumes of 0.75% monobasic ammonium phosphate solution(adjusted at pH 7.0 with diiopropylamine) with 30 volumes of acetonitrile. The wavelength detection was set at 215 nm, the injection volumn was 10 μL, and the flow rate was 1.0 mL·min-1. Results: Levamisole and its impurities were separated well by related substances HPLC method above. Impurities A, B, C, D, E showed the good linearities in the concentration ranges of 10.87-25.37 μg·mL-1, 11.62-27.10 μg·mL-1, 12.38-28.90 μg·mL-1, 30.89-72.07 μg·mL-1, 12.41-28.95 μg·mL-1 (r＞0.999). The average correction factors of impurities A, B, C, D, E determined by three columns and liquid chromatographies were 1.6, 1.4, 2.6, 1.2, 2.4, respectively, the recovery rates(n=9) were 98.1%, 99.0%, 98.6%, 100.1%, 99.9% and the RSDs were 0.63%, 0.79%, 0.92%, 0.96%, 0.33%. The separation of levamisole and impurity C was good by assay HPLC method. Levamisole showed the good linearity in the concentration range of 0.10 14-0.304 3 mg·mL-1 (r=0.999 9). The average recovery rate(n=9) of levamisole was 100.2%, RSD=0.52%. Ten batches levamisole hydrochloride tablets from five domestic pharmaceutical enterprises were determined by the above related substances and assay HPLC method, the total impurities mass were 0.05%-0.62%, and the assays were 99.5%-104.3%. Conclusion: The established method is high selection and accurate. It is suitable applied for determination of related substances and assay of levamiole hydrochloride tablets.
BAO Shi, ZHAO Ya-ping, CAO Quan-sheng
. Determination of related substances and assay of levamisole hydrochloride tablets by HPLC*[J]. Chinese Journal of Pharmaceutical Analysis, 2024
, 44(4)
: 705
-713
.
DOI: 10.16155/j.0254-1793.2024.04.17
[1] 窦晓群, 卫延辉, 郭学军. 左旋咪唑临床应用进展及免疫调节机制探讨[J]. 现代免疫学, 2021, 41(2):173
DOU XQ, WEI YH, GUO XJ. Progress in the clinical application of levamisole and its immunomodulatory mechanism[J]. Curr Immunol, 2021, 41(2):173
[2] 中华人民共和国药典 2020年版. 二部[S]. 2020: 1078
ChP 2020. Vol Ⅱ[S]. 2020: 1078
[3] 丁莉倩. 盐酸左旋咪唑滴丸的制备与含量测定[J]. 化工设计通讯, 2022, 48(8):192
DING LQ. Preparation and content determination of levamisole hydrochloride dropping pills[J]. Chem Eng Design Commun, 2022, 48(8):192
[4] WHO. Model List of Essential Medicines-23nd List[DB/OL]. World Health Organization(2023-07-26) [2024-01-31]. https://www. who. int/publications/i/item/WHO-MHP-HPS-EML-2023. 02
[5] KUMAR L,YADAV YS, RATHNANAND M. simultaneous determination of linezolid and levamisole hydrochloride in a fixed dose combination[J]. Indian J Pharm Educ Res, 2017, 51(4):613
[6] ABDEL-AZIZ O, HUSSIEN EM, KOSASY AM, et al. Comparative study of univariate spectrophotometry and multivariate calibration for the determination of levamisole hydrochloride and closantel sodium in a binary mixture[J]. J AOAC Int, 2016, 99(4):941
[7] 邢亚非, 钱小燕. 盐酸左旋咪唑中对甲苯磺酞氯杂质测定方法的建立[J]. 中国医药指南, 2014, 12(19):107
XING YF, QIAN XY. Established of a method for the determination of toluenesulphthalide chloride in levamisole hydrochloride[J]. Guide China Med, 2014, 12(19):107
[8] 郭江红, 赵亚萍, 吴蔚. HPLC法测定盐酸左旋咪唑中有关物质[J]. 中国药师, 2012, 15(4):512
GUO JH, ZHAO YP, WU W. Determination of related substances in levamisole hydrochloride by HPLC[J]. China Pharm, 2012, 15(4):512
[9] 郭江红, 赵亚萍. HPLC法测定复方甲苯咪唑片中甲苯咪唑和盐酸左旋咪唑的含量[J]. 中国药品标准, 2010, 11(3):219
GUO JH, ZHAO YP. Content determination of mebendazole and levamisole hydrochloride in compound mebendazole tablets by HPLC[J]. Drug Stand China, 2010, 11(3):219
[10] 陆兴毅. HPLC法测定盐酸左旋咪唑糖浆的含量[J]. 药物分析杂志, 2008, 28(10):1753
LU XY. HPLC determination of levamisole hydrochloride syrup[J]. Chin J Pharm Anal, 2008, 28(10):1753
[11] 李洁, 林慧菁. HPLC法测定盐酸左旋咪唑糖浆的含量[J]. 中国现代药物应用, 2009, 3(19):22
LI J, LIN HJ. HPLC determination of levamisole hydrochloride syrup[J]. Chin J Mod Drug Appl, 2009, 3(19):22
[12] 邱涵. GC法测定盐酸左旋咪唑片的含量[J]. 中国药品标准, 2007, 8(5):45
QIU H. Determination of levamisole hydrochloride in levamisole hydrochloride tablets by gas chromatography[J]. Drug Stand China, 2007, 8(5):45
[13] 侯爱荣, 邹爱玲, 黄桂玲, 等. 对盐酸左旋咪唑片增加旋光度检查的建议[J].中国药品标准, 2004, 5(3):16
HOU AR, ZOU AL, HUANG GL, et al. Suggested to increase the optical rotation of levamisole hydrochloride tablets[J]. Drug Stand China, 2004, 5(3):16
[14] 李忠红, 张玫, 樊夏雷, 等. 三国药典盐酸左旋咪唑片含量测定方法比较[J]. 中国药事, 2011, 25(5):497
LI ZH, ZHANG M, FAN XL, et al. Comparison of determination methods of levamisole tablets in three pharmacopoeias[J]. Chin Pharm Aff, 2011, 25(5):497
[15] 王勇忠. 高效液相色谱法测定盐酸左旋咪唑搽剂的含量[J]. 海峡药学, 2007, 19(12):52
WANG YZ. Determination the content in of levamisole hydrochloride liniment by HPLC[J]. Strait Pharm J, 2007, 19(12):52
[16] 杨林, 丁莉坤, 周伦. 左旋咪唑2种搽剂的人体药动学及生物等效性[J]. 中国新药与临床杂志, 2011, 30(9):694
YANG L, DING LK, ZHOU L. Pharmacokinetics and bioequivalence of two kinds of levamisole liniment in healthy volunteers[J]. Chin J New Drugs Clin Remed, 2011, 30(9):694
[17] 郭萌. 三种方法检验盐酸左旋咪唑片剂含量的方法比较[J]. 安徽医药, 2011, 15(9):1080
GUO M. A comparison among three kinds of methods to test the content of levamisole hydrochloride tablets[J]. Anhui Med Pharm J, 2011, 15(9):1080
